- China’s Innogen expects to complete weight-loss drug trials next year Reuters
- Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss Medscape
- Chinese Biotech Showcases Challenger to Eli Lilly’s Obesity Drug Bloomberg
- Data from the Phase 2 Clinical Trial of CX11/VCT220 in China Presented at ADA 2025 GlobeNewswire
- ADA: Ecnoglutide Yields Superior, Sustained Reduction in Body Weight Endocrinology Advisor